BACR Annual Meeting 2023
Circadian cycle, chronobiology and cancer
Program Registration Abstract Venue Sponsors
THE ONLINE ABSTRACT BOOK WILL BE AVAILABLE HERE.
Scientific committee: BACR Board
| 9:00 | Registration, poster mounting & coffee |
| 9:30 – 12:15 | MORNING SESSION Chair: Prof. Olivier Feron |
| 9:30 | Introduction (local organizers) |
| 9:45 |
Zai Diamantopoulou, Cancer Research UK, Beatson Institute, Glasgow, UK
The metastatic spread of breast cancer accelerates during sleep
|
| 10:30 |
Eva Hadadi, Laboratory of Cellular and Molecular Immunology (CMIM), VUB; Lab of Dendritic Cell Biology and Cancer Immunotherapy (DCBCI) & Laboratory for Myeloid Cell Immunology (MCI), VIB IRC, Brussels, Belgium
Circadian clock machinery in anti-tumor immunity
|
| 11:00 – 11:30 | Coffee break & Poster viewing |
| 11:30 | Young investigators: oral presentations of 4 selected abstracts Eva Blondeel (Ugent), Time-induced tissue dynamics impact spheroid heterogeneity and drug responses: consequences for functional precision medicine drug screenings. Rebekah Crake (ULiège), Identifying targetable metabolic adaptations in drug tolerant BRAFV600E mutant non-small cell lung cancer. Tias Verhezen (UAntwerp), Prevention of hypoxia-induced natural killer cell dysfunction through maintenance of mitochondrial health. Morgane Paque (ULiège), mTORC2-dependent reprogramming of lipid metabolism supports lung cancer progression. |
| 12:30 | BACR: general assembly (members only) |
| 12:30 – 14:15 | LUNCH AND POSTER SESSION |
| 14:15 – 17:00 | AFTERNOON SESSION Chair: Prof. Akeila Bellahcène |
| 14:15 | Young investigators: oral presentations of 4 selected abstracts
Lisa Kerkhove (VUB), Role of ferroptosis in radiation-induced cell death. Charline Degavre (UCLouvain), In situ photodynamic therapy induction of immunogenic cell death to boost dendritic cellbased immunotherapy of peritoneal carcinomatosis. Astrid Van den Eynde (UAntwerp), CD70 holds great therapeutic potential to target tumor cells and cancer-associated fibroblasts in the microenvironment by IL-15 boosted CD70-CAR natural killer cells. Raphaël Peiffer (ULiège), Myoferlin, a new drug target in pancreatic CAFs to tackle desmoplasia and tumor aggressiveness. |
| 15:15 | Coffee break |
| 15:45 |
Zeng Qun, Department of Pathology and Immunology, Centre Médical Universitaire (CMU), University of Geneva, Switzerland
Cancer chronotherapy through the targeting of the circadian immune system
|
| 16:15 |
Léo Aubert, Cancer Translational Research Lab, IREC, UCLouvain, Brussels, Belgium
Deciphering the interplay between circadian rhythms and cancer cell metabolism |
| 16:45 | Awards ceremony for best oral and poster presentations Concluding remarks |
| 17:00 | End of conference |